SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Q1 Trading Update

19 Apr 2018 07:00

RNS Number : 3888L
Rentokil Initial PLC
19 April 2018
Β 

Β 

RENTOKIL INITIAL PLC (RTO)

FIRST QUARTER TRADING UPDATE

19 April 2018

Β 

(Β£m)

Β 

Q1 2018

Growth

Β 

Β 

AER

AER

CER

Ongoing Revenue1

Β 

545.9

10.8%

15.7%

Revenue

Β 

550.7

-5.1%

-1.5%

Β 

Overview

Trading has started well across our businesses in Q1 with Ongoing Revenue increasing by 15.7%.

Organic Revenue2 Growth of 3.2% compares to Q1 2017 at 3.7%* (3.1% Reported) and Q4 2017 (3.1%). Organic growth has been affected by the ongoing impact of last September's hurricane on our operations in Puerto Rico (as previously highlighted at the time of our Preliminary results) and unseasonably cold weather in the US in March which has delayed the onset of the spring pest season. Excluding the impact of Puerto Rico, 2018 Q1 Organic growth is in line with Q1 2017.

Acquisitions have performed well contributing 12.5% to Ongoing Revenue in the first quarter.

Ongoing Revenue in Pest Control grew by 15.8% (4.7% Organic, Q1 2017: 5.6%, Q4 2017: 4.9%) with Growth markets growing by 12.4% and Emerging markets increasing by 38.2%, reflecting the strong performance of our joint venture in India.

Q1 2018 Hygiene Ongoing Revenue rose by 29.3% (1.8% Organic, Q1 2017: 3.4%, Q4 2017: -0.2%), driven by the acquisitions of Cannon Hygiene and CWS Italy.

Ongoing Revenue in our Protect & Enhance markets declined by -0.1% (-0.3 Organic, Q1 2017: -0.9%, Q4 2017: 1.0%) due to ongoing market weakness in our UK Property Care business, offset by a stronger performance from our French business.

While currency markets remain volatile, our guidance for the adverse impact of foreign exchange on profit is in the range of Β£10m to Β£15m for the year, as previously guided at the Preliminary results on 1 March 2018.

M&AΒ 

​In the three months to 31 March 2018 we made 11 pest control acquisitions (five in North America with annualised revenues of $27m) in addition to the Cannon Hygiene businesses acquired in January. Combined annualised revenues of the 12 businesses acquired was Β£103.0m in the year prior to purchase. Our guidance for M&A spend remains in the range of Β£200m to Β£250m which will be funded by cash held on the balance sheet at the beginning of the year. We are encouraged about our prospects for further M&A this year and our pipeline of value-enhancing opportunities is strong.

​Commenting on today's announcement Andy Ransom, Chief Executive, said:

"I am pleased with our performance in Q1 and we are well-positioned for another year of successful growth. We are confident that the Company will deliver a performance in line with market expectations for 2018."

Β 

Enquiries:

Β 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Β 

Β 

Β 

Β 

Media:

Malcolm Padley

Rentokil Initial plc

07788 978 199

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

1Ongoing Revenue represents the performance of the continuing operations of the Group (including acquisitions) after removing the effect of disposed or closed businesses.

Β 

2Organic Revenue represents the growth in Ongoing Revenue excluding the effect of businesses acquired during the year. Acquired businesses are included in organic measures in the year following acquisition, and the comparative period is adjusted to include an estimated full year performance for growth calculations.

Β 

*In Q1 2017 the Company reported Organic growth of 3.1% in Q1 but noted that excluding the businesses transferred to the Haniel JV, the Organic growth figure would have been 3.5%. We have further adjusted this number to exclude the eight French flat linen laundries sold to RLD in H2 2017, which results in a revised comparative number for Q1 2017 of 3.7%.

Β 

AER - actual exchange rates; CER - constant 2017 exchange rates

Β 

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTMMGMDNRFGRZM
Date   Source Headline
11th Jan 20084:08 pmRNSHolding(s) in Company
10th Jan 200810:19 amRNSHolding(s) in Company
27th Dec 200710:11 amRNSDisposal
21st Dec 20079:57 amRNSHolding(s) in Company
20th Dec 200712:18 pmRNSDirector/PDMR Shareholding
18th Dec 20074:37 pmRNSDirector/PDMR Shareholding
14th Dec 20074:48 pmRNSHolding(s) in Company
14th Dec 200712:39 pmRNSDirector/PDMR Shareholding
13th Dec 20074:19 pmRNSDirector/PDMR Shareholding
13th Dec 20077:01 amRNSTrading Statement
12th Dec 200710:28 amRNSHolding(s) in Company
8th Nov 20077:01 amRNS3rd Quarter Results
19th Oct 200712:27 pmRNSAnnual Calendar 2008
17th Oct 20072:47 pmRNSHolding(s) in Company
8th Oct 20074:16 pmRNSDirector/PDMR Shareholding
1st Oct 20074:20 pmRNSTotal Voting Rights
28th Sep 20074:43 pmRNSDirector/PDMR Shareholding
25th Sep 200710:09 amRNSHolding(s) in Company
23rd Aug 20077:00 amRNSInterim Results
8th Aug 20072:57 pmRNSHolding(s) in Company
31st Jul 20079:50 amRNSTotal Voting Rights
30th Jul 200710:55 amRNSHolding(s) in Company
30th Jul 20077:01 amRNSAcquisition
19th Jul 20077:00 amRNSDirectorate Change
17th Jul 20077:00 amRNSAcquisition
9th Jul 200712:38 pmRNSHolding(s) in Company
2nd Jul 20074:27 pmRNSDisposal
29th Jun 200712:04 pmRNSHolding(s) in Company
27th Jun 20074:16 pmRNSRegulatory Inquiry Outcome
21st Jun 200710:47 amRNSHolding(s) in Company
11th Jun 200710:41 amRNSHolding(s) in Company
31st May 20074:27 pmRNSTotal Voting Rights
24th May 200710:01 amRNSHolding(s) in Company
3rd May 20075:50 pmRNSAGM Statement
2nd May 20077:01 amRNSTrading Update
1st May 20073:43 pmRNSTotal Voting Rights
24th Apr 20071:21 pmRNSCorporate Responsibility Rev
20th Apr 20078:00 amRNSDoc re. Company News
20th Apr 20078:00 amRNSAcquisition
19th Apr 200711:39 amRNSAnnual Information Update
30th Mar 20072:41 pmRNSAnnual Report and Accounts
30th Mar 20077:04 amRNSDisposal
15th Mar 20077:02 amRNSRentokil Tropical Plants
13th Mar 20079:04 amRNSHolding(s) in Company
7th Mar 20074:52 pmRNSDirector/PDMR Shareholding
7th Mar 200712:25 pmRNSStatement re: OFT clearance
28th Feb 20075:00 pmRNSDirector/PDMR Shareholding
22nd Feb 20077:02 amRNSFinal Results
21st Feb 20075:09 pmRNSHolding(s) in Company
31st Jan 20075:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.